Clinical trial · Observational
A Study to Follow up Recurrence Rates of Actinic Keratoses One Year After Completion of Study 1487-IMIQ
A Follow-up Study to Evaluate Actinic Keratosis Recurrence Rates One Year After Completion of the 1487-IMIQ Study
NCT00189254CI-TRIAL-00056350completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of the study is to obtain recurrence rates and long-term safety data for patients who had been treating actinic keratoses on the face and scalp with 5 % Imiquimod Cream in a previous study.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Actinic Keratoses | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Imiquimod | Drug | Imiquimod | ALIAS |
Design
Arms and outcomes
Arms (1)
- label
- Imiquimod 5% cream
- description
- No investigational treatments were given during this study.
- interventionNames
- Drug: Imiquimod
Primary outcomes (3)
- measure
- Efficacy
- timeFrame
- one year after completion of study 1487-Imiq
- description
- Efficacy was evaluated by counting AK lesions in the previous treatment area. Subjects at the 1-year follow-up visit with recurrence of lesion(s).
- measure
- Safety
- timeFrame
- one year after completion of study 1487-Imiq
- description
- Safety was evaluated by assessing the area of previous treatment for LSRs and skin quality
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * 100% clearance of Actinic Keratosis (AK) lesions in the 1487 IMIQ study Exclusion Criteria: * used any treatments in the previous treatment area within 24 hours prior to the follow-up visit
References
Publications (0)
Data not yet available
No reference posted for this study.